Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 323

Similar articles for PubMed (Select 18781705)

1.

Evaluation of body mass index, pre-vaccination serum progesterone levels and anti-anthrax protective antigen immunoglobulin G on injection site adverse events following anthrax vaccination in women.

Zhang Y, Martin SW, Rose CE Jr, Biagini RE, Franzke LH, Smith JP, Sammons DL, Robertson SA, McNeil MM.

Pharmacoepidemiol Drug Saf. 2008 Nov;17(11):1060-7. doi: 10.1002/pds.1657.

PMID:
18781705
2.

Evaluation of sex, race, body mass index and pre-vaccination serum progesterone levels and post-vaccination serum anti-anthrax protective immunoglobulin G on injection site adverse events following anthrax vaccine adsorbed (AVA) in the CDC AVA human clinical trial.

Pondo T, Rose CE Jr, Martin SW, Keitel WA, Keyserling HL, Babcock J, Parker S, Jacobson RM, Poland GA, McNeil MM.

Vaccine. 2014 Jun 12;32(28):3548-54. doi: 10.1016/j.vaccine.2014.04.025. Epub 2014 Apr 24.

PMID:
24768633
3.

Analysis of anti-protective antigen IgG subclass distribution in recipients of anthrax vaccine adsorbed (AVA) and patients with cutaneous and inhalation anthrax.

Semenova VA, Schmidt DS, Taylor TH Jr, Li H, Steward-Clark E, Soroka SD, Ballard MM, Quinn CP.

Vaccine. 2007 Feb 26;25(10):1780-8. Epub 2006 Nov 27.

PMID:
17229495
4.

Rapid, sensitive, and specific lateral-flow immunochromatographic device to measure anti-anthrax protective antigen immunoglobulin g in serum and whole blood.

Biagini RE, Sammons DL, Smith JP, MacKenzie BA, Striley CA, Snawder JE, Robertson SA, Quinn CP.

Clin Vaccine Immunol. 2006 May;13(5):541-6.

5.

Effect of reduced dose schedules and intramuscular injection of anthrax vaccine adsorbed on immunological response and safety profile: a randomized trial.

Wright JG, Plikaytis BD, Rose CE, Parker SD, Babcock J, Keitel W, El Sahly H, Poland GA, Jacobson RM, Keyserling HL, Semenova VA, Li H, Schiffer J, Dababneh H, Martin SK, Martin SW, Marano N, Messonnier NE, Quinn CP.

Vaccine. 2014 Feb 12;32(8):1019-28. doi: 10.1016/j.vaccine.2013.10.039. Epub 2013 Dec 25.

PMID:
24373307
6.

Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans.

Pittman PR, Kim-Ahn G, Pifat DY, Coonan K, Gibbs P, Little S, Pace-Templeton JG, Myers R, Parker GW, Friedlander AM.

Vaccine. 2002 Jan 31;20(9-10):1412-20.

PMID:
11818160
7.

The anthrax vaccine: no new tricks for an old dog.

Bienek DR, Loomis LJ, Biagini RE.

Hum Vaccin. 2009 Mar;5(3):184-9. Epub 2009 Mar 2. Review.

8.

A three-dose intramuscular injection schedule of anthrax vaccine adsorbed generates sustained humoral and cellular immune responses to protective antigen and provides long-term protection against inhalation anthrax in rhesus macaques.

Quinn CP, Sabourin CL, Niemuth NA, Li H, Semenova VA, Rudge TL, Mayfield HJ, Schiffer J, Mittler RS, Ibegbu CC, Wrammert J, Ahmed R, Brys AM, Hunt RE, Levesque D, Estep JE, Barnewall RE, Robinson DM, Plikaytis BD, Marano N; AVRP Laboratory Working Group.

Clin Vaccine Immunol. 2012 Nov;19(11):1730-45. doi: 10.1128/CVI.00324-12. Epub 2012 Aug 29.

9.
10.

An overview of adverse events reported by participants in CDC's anthrax vaccine and antimicrobial availability program.

Martin SW, Tierney BC, Aranas A, Rosenstein NE, Franzke LH, Apicella L, Marano N, McNeil MM.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):393-401.

PMID:
15717323
11.

Factors influencing laboratory workers' decisions to accept or decline anthrax vaccine adsorbed (AVA): results of a decision-making study in CDC's anthrax vaccination program.

Fowler GL, Baggs JM, Weintraub ES, Martin SW, McNeil MM, Gust DA.

Pharmacoepidemiol Drug Saf. 2006 Dec;15(12):880-8.

PMID:
16924600
12.

Immunological dynamics in response to two anthrax vaccines in mice.

L├╝ J, He R, Dong M, Zhang L, Wang X.

Sci China C Life Sci. 2008 Oct;51(10):872-8. doi: 10.1007/s11427-008-0119-4. Epub 2008 Sep 26.

PMID:
18815750
13.

Determination of serum IgG antibodies to Bacillus anthracis protective antigen in environmental sampling workers using a fluorescent covalent microsphere immunoassay.

Biagini RE, Sammons DL, Smith JP, Page EH, Snawder JE, Striley CA, MacKenzie BA.

Occup Environ Med. 2004 Aug;61(8):703-8.

14.

Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers.

Rynkiewicz D, Rathkopf M, Sim I, Waytes AT, Hopkins RJ, Giri L, DeMuria D, Ransom J, Quinn J, Nabors GS, Nielsen CJ.

Vaccine. 2011 Aug 26;29(37):6313-20. doi: 10.1016/j.vaccine.2011.05.047. Epub 2011 May 30.

PMID:
21624418
15.

Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: a randomized, double-blinded, controlled, multicenter trial.

Gorse GJ, Keitel W, Keyserling H, Taylor DN, Lock M, Alves K, Kenner J, Deans L, Gurwith M.

Vaccine. 2006 Aug 14;24(33-34):5950-9. Epub 2006 Jun 5.

PMID:
16797805
16.

Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).

Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, Ward BJ, West DJ.

Pharmacoepidemiol Drug Saf. 2004 Dec;13(12):825-40. Review.

PMID:
15386719
17.

Safety, reactogenicity and immunogenicity of a recombinant protective antigen anthrax vaccine given to healthy adults.

Campbell JD, Clement KH, Wasserman SS, Donegan S, Chrisley L, Kotloff KL.

Hum Vaccin. 2007 Sep-Oct;3(5):205-11. Epub 2007 May 18.

18.

Detection of anti-protective antigen salivary IgG antibodies in recipients of the US licensed anthrax vaccine.

Bienek DR, Chang CK, Cohen ME.

Vaccine. 2007 Aug 10;25(32):5978-84. Epub 2007 Jun 11.

PMID:
17597265
19.

Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series.

Pittman PR, Norris SL, Barrera Oro JG, Bedwell D, Cannon TL, McKee KT Jr.

Vaccine. 2006 Apr 24;24(17):3654-60. Epub 2006 Feb 9.

PMID:
16497418
20.

Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid.

Pittman PR, Hack D, Mangiafico J, Gibbs P, McKee KT Jr, Friedlander AM, Sjogren MH.

Vaccine. 2002 May 15;20(16):2107-15.

PMID:
11972980
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk